Utility of cmv-specific immune monitoring for the management of cmv in solid organ transplant recipients: A clinical update

Katya Prakash, Aditya Chandorkar, Kapil K. Saharia

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ transplant (SOT) recipients. However, current techniques used to predict risk for CMV infection fall short. CMV-specific cell mediated immunity (CMI) plays an important role in protecting against CMV infection. There is evidence that assays measuring CMV-CMI might better identify SOT recipients at risk of complications from CMV compared to anti-CMV IgG, which is our current standard of care. Here, we review recently published studies that utilize CMV-CMI, at various points before and after transplantation, to help predict risk and guide the management of CMV infection following organ transplantation. The evidence supports the use of these novel assays to help identify SOT recipients at increased risk and highlights the need for larger prospective trials evaluating these modalities in this high-risk population.

Original languageEnglish (US)
Article number875
JournalDiagnostics
Volume11
Issue number5
DOIs
StatePublished - May 13 2021

Bibliographical note

Funding Information:
Funding: This research received no external funding. The APC was funded by Eurofins Viracor, Inc. (Lee’s Summit, MO, USA).

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • CD4+ T cell
  • CD8+ T cell
  • Cell-mediated immunity
  • CMV
  • ELISA
  • ELISpot
  • Flow cytometry
  • Solid organ transplant

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Utility of cmv-specific immune monitoring for the management of cmv in solid organ transplant recipients: A clinical update'. Together they form a unique fingerprint.

Cite this